Jason Lettmann Alx Oncology Holdings Inc (ALXO) insider trading activity

Jason Lettmann is CHIEF EXECUTIVE OFFICER of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 305,121 shares of ALXO, which is worth approximately $320,377. The most recent transaction as insider was on Sep 17, 2025, when has been sold 71,163 shares (Common Stock) at a price of $1.08 per share, resulting in proceeds of $76,856. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 305K

43.74% 3M change

80.09% 12M change

Total Value Held $320,377

Jason Lettmann Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 17 2025	BUY Open market or private purchase	$76,856 $1.08 p/Share	71,163 Added 18.91%	305,121 Common Stock
Sep 16 2025	BUY Open market or private purchase	$22,544 $1.07 p/Share	21,070 Added 8.26%	233,958 Common Stock
Aug 15 2025	SELL Open market or private sale	$1,524 $0.64 p/Share	2,382 Reduced 1.11%	212,888 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	-	42,000 Added 16.52%	212,270 Common Stock
Feb 19 2025	SELL Open market or private sale	$2,482 $1.15 p/Share	2,159 Reduced 1.25%	170,270 Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$5,652 $2.58 p/Share	2,191 Reduced 1.28%	169,429 Common Stock
Mar 14 2024	BUY Open market or private purchase	$49,764 $11.31 p/Share	4,400 Added 2.5%	171,620 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	60,000 Added 26.41%	167,220 Common Stock

Jason Lettmann

CHIEF EXECUTIVE OFFICER

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Value

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Track Activities on ALXO

Account